title: Complications of multimodality therapy.
abstract: Multimodality therapy may further increase treatment-related complications. However, such therapy may be necessary for advanced or biologically aggressive tumors, and information gained from patient entry into prospective trials may attenuate current and future treatment-related complications. Ad hoc use of multimodality therapies is generally not recommended.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, University of Texas M.D. Anderson Cancer Center, Houston, USA. putnam@notes.mdacc.tmc.edu
authors.forename: J B
authors.initials: JB
authors.lastname: Putnam
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D003131:Combined Modality Therapy / Q000009:adverse effects; D004938:Esophageal Neoplasms / Q000473:pathology / Q000628:therapy; D006801:Humans; D009367:Neoplasm Staging; D013899:Thoracic Neoplasms / Q000188:drug therapy / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents